Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline.
Dept of Infectious Diseases, Galliera Hospital, Genoa, Italy.
Emanuele
E
Pontali
World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy.|Public Health Consulting Group, Lugano, Switzerland.
Lia
L
D'Ambrosio
World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy.
Rosella
R
Centis
Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari, Italy.
Giovanni
0000-0002-1600-4474
G
Sotgiu
World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.
Giovanni Battista
0000-0002-2597-574X
GB
Migliori
D000995:Antitubercular Agents / Q000627:therapeutic use*; D064687:Diarylquinolines / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014944:World Health Organization
D000995:Antitubercular Agents; D064687:Diarylquinolines; C493870:bedaquiline